AstraZeneca's Koselugo receives EU approval
28th Oct 2025 07:03
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that its Koselugo asset has been approved for usage in the European Union for the rare, progressive, genetic condition, plexiform neurofibromas, in adults with neurofibromatosis type 1.
Read moreAstrazeneca's Tezspire secures EU approval
22nd Oct 2025 08:00
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its chronic rhinosinusitis with nasal polyps treatment, Tezspire, has been approved in the European Union as an add-on therapy with intranasal corticosteroids for adults.
Read moreAstraZeneca lupus treatment gets EU approval
20th Oct 2025 07:03
(Sharecast News) - AstraZeneca has received the green light from European regulators for its Saphnelo treatment for lupus, the pharma giant announced on Monday.
Read moreDeutsche Bank downgrades AstraZeneca to 'sell'
16th Oct 2025 10:24
(Sharecast News) - Deutsche Bank downgraded AstraZeneca to 'sell' from 'hold' on Thursday and cut the price target to 10,500p from 11,500p as it said it was turning sceptical on SERENA-4.
Read moreAstraZeneca to cut US drug prices in key White House deal
13th Oct 2025 07:01
(Sharecast News) - AstraZeneca has struck a deal with the White House to cut drugs prices in America, allowing it to avoid steep tariffs on US imports.
Read moreAstraZeneca's Baxdrostat hits Phase III endpoint in resistant hypertension
7th Oct 2025 07:27
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Baxdrostat had met its primary endpoint in the Bax24 Phase III trial, delivering a "statistically significant and clinically meaningful reduction" in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension.
Read moreLondon midday: Stocks mixed with French and US fiscal impasses in focus
6th Oct 2025 11:13
(Sharecast News) - Stocks in London were trading on a mixed note around the midday mark, but had stabilised despite news of the French Prime Minister's resignation after just a month on the job.
Read moreLondon midday: UK stocks keep grinding towards year's highs
3rd Oct 2025 11:15
(Sharecast News) - Stocks are moving higher still shortly before midday with investor sentiment buoyed by fresh bullish news around the artificial intelligence space, even as investors keep a wary eye on the ongoing budget standoff in Washington D.C..
Read moreTrump's MFN deal with Pfizer could be bellwether for pharma sector, says JPM
1st Oct 2025 09:26
(Sharecast News) - US President Donald Trump's 'Most Favoured Nation' deal with Pfizer could be a bellwether for the pharmaceutical sector and reassure investors over a broadly manageable impact, JPMorgan said in a research note
Read moreAstraZeneca to list in New York, retain London
29th Sep 2025 09:24
(Sharecast News) - Anglo-Swedish drugs giant AstraZeneca is to list directly on the New York Stock Exchange, it was announced on Monday.
Read moreTrump to impose tariffs of 100% on branded drug imports
26th Sep 2025 07:53
(Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US president's global trade war.
Read moreEU approves AstraZeneca's Tezspire to treat nasal conditions
22nd Sep 2025 07:06
(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.
Read moreLondon close: Stocks mixed ahead of central bank decisions
15th Sep 2025 17:51
(Sharecast News) - London stocks ended mixed on Monday as investors adopted a cautious stance ahead of a series of major central bank policy decisions due later this week.
Read moreAstraZeneca to pause £200m Cambridge investment, shares slump
15th Sep 2025 08:58
(Sharecast News) - AstraZeneca slumped on Monday after saying it was pausing plans to invest £200m at its Cambridge research site.
Read moreLondon close: Stocks fall on Trump's latest tariffs, US jobs data
1st Aug 2025 17:37
(Sharecast News) - London stocks ended the week lower on Friday as investors reacted to a fresh wave of US tariffs and disappointing economic data from the United States.
Read more